Pioneers in the synbio revolutionIs synthetic biology on the cusp of unlocking the next industrial revolution? A major roadblock is the ability to synthesise DNA for R&D in ways that are both cheap and efficient. Established players … more ➔
Cutting time to market for high quality therapeuticsThe demand for the fast and robust development of manufacturing cell lines is ever growing, with an increasing number of therapeutic proteins in development. To fulfill these needs, Celonic engineered … more ➔
IMI fosters antibiotics research amidst Big Pharma pullbacksThe Innovative Medicines Initiative 2 (IMI2) has launched a new Antimicrobial Resistance Accelerator Programme following on the heels of its outgoing NewDrugs4BadBugs programme. more ➔
Experts discuss process intensificationRoughly 150 life science professionals met at the 5th Biotech Days to discuss the latest progress in bioprocess intensification. more ➔
Managing complexity to bring drugs to clinic fasterIntegrating the disparate stages of drug development is the most time and cost-efficient way of turning a promising candidate compound into a pharmaceutical product. A CDMO that offers coordinated end-to-end … more ➔
The future of agrochemistryOne of the world’s largest and most controversial mergers in the past few years was sealed in early June. German pharma and chemistry company Bayer has taken over US competitor Monsanto, forming the … more ➔
Closing the gap in haemophilia therapyAbout 25% of the people who suffer from haemophilia A have no therapeutic options, because their immune system forms antibodies against clotting products that can stop bleeding. Researchers and companies … more ➔
A global CMO for medical mediaBiological Industries (BI) develops, manufactures, packs, and supplies cell culture products for academic research, diagnostic labs, hospitals, and the biotechnology and biopharmaceutical industries. … more ➔
Nanobots: Fiction becoming realityOnce confined to speculative and science fiction, miniature micro- or nanobots targeting pathogens or conditions directly have now become reality in research labs worldwide. But to enter clinical trials, … more ➔
Crowdfunding goes blockchainSpanish Capital Cell continues to be a pioneer in the health crowdfunding scene and launched a new self-funding fundraising round to create the first ICO marketplace for health via Blockchain. more ➔
